Genetic analysis of lysosomal alpha-galactosidase A gene in sporadic Parkinson's disease

Neuroscience Letters

Volumn 500, Issue 1, 2011, Pages 31-35

  Wu, Guanghua ^a   Pang, Shuchao ^a   Feng, Xungang ^a   Zhang, Aimei ^a   Li, Jifeng ^a   Gu, Kejin ^a   Huang, Jian ^a   Dong, Haixin ^a   Yan, Bo ^a  

^a JINING MEDICAL UNIVERSITY   (China)

Author keywords

Alpha galactosidase A; Lysosome; Parkinson's disease; Single nucleotide polymorphisms

Indexed keywords

ALPHA GALACTOSIDASE; ALPHA SYNUCLEIN; GENOMIC DNA; LYSOSOME ENZYME; RNA;

5' UNTRANSLATED REGION; ADULT; AGED; ALPHA GALACTOSIDASE A GENE; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; EXON; FEMALE; GENE; GENE FREQUENCY; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SPORADIC PARKINSON DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-GALACTOSIDASE; FEMALE; HUMANS; LYSOSOMES; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 79960291245     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.05.238     Document Type: Article

References (39)

1. Aharon-Peretz J., Rosenbaum H., Gershoni-Baruch R. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N. Engl. J. Med. 2004, 351:1972-1977.
2. Alvarez-Erviti L., Rodriguez-Oroz M.C., Cooper J.M., Caballero C., Ferrer I., Obeso J.A., Schapira A.H. Chaperone-mediated autophagy markers in Parkinson disease brains. Arch. Neurol. 2010, 67:1464-1472.
3. Anglade P., Vyas S., Javoy-Agid F., Herrero M.T., Michel P.P., Marquez J., Mouatt-Prigent A., Ruberg M., Hirsch E.C., Agid Y. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol. 1997, 12:25-31.
4. Bandopadhyay R., de Belleroche J. Pathogenesis of Parkinson's disease: emerging role of molecular chaperones. Trends Mol. Med. 2010, 16:27-36.
5. Banerjee R., Beal M.F., Thomas B. Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications. Trends Neurosci. 2010, 33:541-549.
6. Bishop D.F., Kornreich R., Desnick R.J. Structural organization of the human alpha-galactosidase A gene: further evidence for the absence of a 3′ untranslated region. Proc. Natl. Acad. Sci. U.S.A. 1988, 85:3903-3907.
7. Borsini W., Giuliacci G., Torricelli F., Pelo E., Martinelli F., Scordo M.R. Anderson-Fabry disease with cerebrovascular complications in two Italian families. Neurol. Sci. 2002, 23:49-53.
8. Buechner S., De Cristofaro M.T., Ramat S., Borsini W. Parkinsonism and Anderson Fabry's disease: a case report. Mov. Disord. 2006, 21:103-107.
9. Chévrier M., Brakch N., Lesueur C., Genty D., Ramdani Y., Moll S., Djavaheri-Mergny M., Brasse-Lagnel C., Laquerrière A., Barbey F., Bekri S. Autophagosome maturation is impaired in Fabry disease. Autophagy 2010, 6:589-599.
10. Cookson M.R., Bandmann O. Parkinson's disease: insights from pathways. Hum. Mol. Genet. 2010, 19:R21-27.
11. Cuervo A.M., Stefanis L., Fredenburg R., Lansbury P.T., Sulzer D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 2004, 305:1292-1295.
12. Cullen V., Lindfors M., Ng J., Paetau A., Swinton E., Kolodziej P., Boston H., Saftig P., Woulfe J., Feany M.B., Myllykangas L., Schlossmacher M.G., Tyynelä J. Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo. Mol. Brain. 2009, 2:5.
13. Desnick R.J., Ioannou Y.A., Eng C.M. α-Galactosidase A deficiency: Fabry disease. The Metabolic and Molecular Bases of Inherited Disease 2001, 3733-3774. McGraw-Hill, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, K.E. Kinzler, B. Vogelstein (Eds.).
14. Garman S.C., Garboczi D.N. The molecular defect leading to Fabry disease: structure of human alpha-galactosidase. J. Mol. Biol. 2004, 337:319-335.
15. Hardy J. Genetic analysis of pathways to Parkinson disease. Neuron 2010, 68:201-206.
16. Hicks A.A., Pétursson H., Jónsson T., Stefánsson H., Jóhannsdóttir H.S., Sainz J., Frigge M.L., Kong A., Gulcher J.R., Stefánsson K., Sveinbjörnsdóttir S. A susceptibility gene for late-onset idiopathic Parkinson's disease. Ann. Neurol. 2002, 52:549-555.
17. Lee H.J., Khoshaghideh F., Patel S., Lee S.J. Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway. J. Neurosci. 2004, 24:1888-1896.
18. Lees A.J., Hardy J., Revesz T. Parkinson's disease. Lancet 2009, 373:2055-2066.
19. Lesage S., Brice A. Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum. Mol. Genet. 2009, 18:R48-59.
20. Levine B., Klionsky D.J. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev. Cell 2004, 6:463-477.
21. Mak S.K., McCormack A.L., Manning-Bog A.B., Cuervo A.M., Di D.A., Monte Lysosomal degradation of alpha-synuclein in vivo. J. Biol. Chem. 2010, 285:13621-13629.
22. Meredith G.E., Totterdell S., Petroske E., Santa Cruz K., Callison R.C., Lau Y.S. Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease. Brain Res. 2002, 956:156-165.
23. Pankratz N., Nichols W.C., Uniacke S.K., Halter C., Rudolph A., Shults C., Conneally P.M., Foroud T. Genome screen to identify susceptibility genes for Parkinson disease in a sample without Parkin mutations. Am. J. Hum. Genet. 2002, 71:124-135. Parkinson Study Group.
24. Ramirez A., Heimbach A., Gründemann J., Stiller B., Hampshire D., Cid L.P., Goebel I., Mubaidin A.F., Wriekat A.L., Roeper J., Al-Din A., Hillmer A.M., Karsak M., Liss B., Woods C.G., Behrens M.I., Kubisch C. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat. Genet. 2006, 38:1184-1191.
25. Scott W.K., Nance M.A., Watts R.L., Hubble J.P., Koller W.C., Lyons K., Pahwa R., Stern M.B., Colcher A., Hiner B.C., Jankovic J., Ondo W.G., Allen F.H., Goetz C.G., Small G.W., Masterman D., Mastaglia F., Laing N.G., Stajich J.M., Slotterbeck B., Booze M.W., Ribble R.C., Rampersaud E., West S.G., Gibson R.A., Middleton L.T., Roses A.D., Haines J.L., Scott B.L., Vance J.M., Pericak-Vance M.A. Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA 2001, 286:2239-2244.
26. Settembre C., Fraldi A., Jahreiss L., Spampanato C., Venturi C., Medina D., de Pablo R., Tacchetti C., Rubinsztein D.C., Ballabio A. A block of autophagy in lysosomal storage disorders. Hum. Mol. Genet. 2008, 17:119-129.
27. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997, 388:839-840.
28. Suzuki K., Iseki E., Katsuse O., Yamaguchi A., Katsuyama K., Aoki I., Yamanaka S., Kosaka K. Neuronal accumulation of alpha- and beta-synucleins in the brain of a GM2 gangliosidosis mouse model. Neuroreport 2003, 14:551-554.
29. Suzuki K., Iseki E., Togo T., Yamaguchi A., Katsuse O., Katsuyama K., Kanzaki S., Shiozaki K., Kawanishi C. Neuronal and glial accumulation of alpha- and beta-synucleins in human lipidoses. Acta Neuropathol. 2007, 114:481-489.
30. Tanislav C., Kaps M., Rolfs A., Böttcher T., Lackner K., Paschke E., Mascher H., Laue M., Blaes F. Frequency of Fabry disease in patients with small-fibre neuropathy of unknown aetiology: a pilot study. Eur. J. Neurol. 2011, 18:631-636.
31. Vogiatzi T., Xilouri M., Vekrellis K., Stefanis L. Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J. Biol. Chem. 2008, 283:23542-23556.
32. Waxman E.A., Giasson B.I. Molecular mechanisms of alpha-synuclein neurodegeneration. Biochim. Biophys. Acta 2009, 1792:616-624.
33. Webb J.L., Ravikumar B., Atkins J., Skepper J.N., Rubinsztein D.C. Alpha-Synuclein is degraded by both autophagy and the proteasome. J. Biol. Chem. 2003, 278:25009-25013.
34. Winklhofer K.F., Haass C. Mitochondrial dysfunction in Parkinson's disease. Biochim. Biophys. Acta 2010, 1802:29-44.
35. Wong E., Cuervo A.M. Autophagy gone awry in neurodegenerative diseases. Nat. Neurosci. 2010, 13:805-811.
36. G. Wu, Z.H. Lu, N. Kulkarni, R. Amin, R.W. Ledeen, Mice lacking major brain gangliosides develop parkinsonism, Neurochem. Res. (2011) in press.
37. Wu G., Wang X., Feng X., Zhang A., Li J., Gu K., Huang J., Pang S., Dong H., Gao H., Yan B. Autophagic alterations in the peripheral leukocytes of patients with sporadic Parkinson's disease. Brain Res. 2011, 1394:105-111.
38. Wu G., Yan B., Wang X., Feng X., Zhang A., Xu X., Dong H. Decreased activities of lysosomal acid alpha-d-galactosidase A in the leukocytes of sporadic Parkinson's disease. J. Neurol. Sci. 2008, 271:168-173.
39. Yu R.K., Nakatani Y., Yanagisawa M. The role of glycosphingolipid metabolism in the developing brain. J. Lipid Res. 2009, 50:S440-445.